These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20695889)

  • 1. Tumor suppressor p16 INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model.
    Sanchez-Ruderisch H; Fischer C; Detjen KM; Welzel M; Wimmel A; Manning JC; André S; Gabius HJ
    FEBS J; 2010 Sep; 277(17):3552-63. PubMed ID: 20695889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells.
    André S; Sanchez-Ruderisch H; Nakagawa H; Buchholz M; Kopitz J; Forberich P; Kemmner W; Böck C; Deguchi K; Detjen KM; Wiedenmann B; von Knebel Doeberitz M; Gress TM; Nishimura S; Rosewicz S; Gabius HJ
    FEBS J; 2007 Jul; 274(13):3233-56. PubMed ID: 17535296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour suppressor p16(INK4a) - anoikis-favouring decrease in N/O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model.
    Amano M; Eriksson H; Manning JC; Detjen KM; André S; Nishimura S; Lehtiö J; Gabius HJ
    FEBS J; 2012 Nov; 279(21):4062-80. PubMed ID: 22943525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor p16INK4a controls oncogenic K-Ras function in human pancreatic cancer cells.
    Rabien A; Sanchez-Ruderisch H; Schulz P; Otto N; Wimmel A; Wiedenmann B; Detjen KM
    Cancer Sci; 2012 Feb; 103(2):169-75. PubMed ID: 22049925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electron microscopy evidence that cytoplasmic localization of the p16(INK4A) "nuclear" cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact. A study in non-small cell lung carcinomas.
    Evangelou K; Bramis J; Peros I; Zacharatos P; Dasiou-Plakida D; Kalogeropoulos N; Asimacopoulos PJ; Kittas C; Marinos E; Gorgoulis VG
    Biotech Histochem; 2004 Feb; 79(1):5-10. PubMed ID: 15223748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptor.
    Plath T; Detjen K; Welzel M; von Marschall Z; Murphy D; Schirner M; Wiedenmann B; Rosewicz S
    J Cell Biol; 2000 Sep; 150(6):1467-78. PubMed ID: 10995450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
    Kim LH; Peh SC; Poppema S
    Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p16 induces transcriptional downregulation of the RB gene.
    Fang X; Jin X; Xu HJ; Liu L; Peng HQ; Hogg D; Roth JA; Yu Y; Xu F; Bast RC; Mills GB
    Oncogene; 1998 Jan; 16(1):1-8. PubMed ID: 9467937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution.
    Gadd M; Pisc C; Branda J; Ionescu-Tiba V; Nikolic Z; Yang C; Wang T; Shackleford GM; Cardiff RD; Schmidt EV
    Cancer Res; 2001 Dec; 61(24):8811-9. PubMed ID: 11751403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
    Leong WF; Chau JF; Li B
    Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer.
    DeInnocentes P; Agarwal P; Bird RC
    J Cell Biochem; 2009 Feb; 106(3):491-505. PubMed ID: 19130492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer.
    Jie G; Zhixiang S; Lei S; Hesheng L; Xiaojun T
    Int J Clin Pract; 2007 Sep; 61(9):1523-9. PubMed ID: 17537196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
    Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
    Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P300 plays a role in p16(INK4a) expression and cell cycle arrest.
    Wang X; Pan L; Feng Y; Wang Y; Han Q; Han L; Han S; Guo J; Huang B; Lu J
    Oncogene; 2008 Mar; 27(13):1894-904. PubMed ID: 17906698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical [corrected] detection of the alternate INK4a-encoded tumor suppressor protein p14(ARF) in archival human cancers and cell lines using commercial antibodies: correlation with p16(INK4a) expression.
    Geradts J; Wilentz RE; Roberts H
    Mod Pathol; 2001 Nov; 14(11):1162-8. PubMed ID: 11706079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
    Khwaja F; Djakiew D
    Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of p16ink4a-binding proteins.
    Souza-Rodrígues E; Estanyol JM; Friedrich-Heineken E; Olmedo E; Vera J; Canela N; Brun S; Agell N; Hübscher U; Bachs O; Jaumot M
    Proteomics; 2007 Nov; 7(22):4102-11. PubMed ID: 17955473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation.
    Kim YJ; Jung JK; Lee SY; Jang KL
    Cancer Lett; 2010 Feb; 288(2):226-35. PubMed ID: 19656618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.